How many clinical trials are tracked of imlifidase?

4 trials are tracked, 0 with published results.

Mode

All Infectious Disease Oncology Neurology Cardiology Psychiatry Diabetes & Endocrinology Pediatrics Allergy & Immunology Rheumatology Gastroenterology Primary Care & Family Medicine Nutrition & Obesity Medicine OB/GYN & Women's Health Orthopedics & Sports Medicine Genetics & Precision Medicine Radiology & Imaging Pulmonology & Critical Care Anesthesiology & Pain Medicine Physical Medicine & Rehab Nephrology Hematology Urology Dermatology Emergency Medicine Ophthalmology Geriatrics & Aging ENT (Otolaryngology) Palliative Care

Research

Clinical Trials Drug Pipeline Weekly Digests

Reference

Conditions Medications

Community

Questions

Text Size

imlifidase

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of imlifidase

4 trials tracked of imlifidase.

4Trials tracked

0Phase 3 & 4

0Recruiting

0With published results

Phase distribution

Phase 2 3 Other / NA 1

Phase 2 An Efficacy and Safety Study of Imlifidase in Treatment of Antibody-Mediated Rejection in Kidney Transplant Patients Completed
Phase 2 Open-Label Phase II Study to Evaluate the Efficacy and Safety of IdeS in Anti-GBM Disease Completed
Phase 2 A Study of Imlifidase in Patients With Guillain-Barré Syndrome Completed
N/A A Follow up Study of Patients Treated With Imlifidase Prior to Kidney Transplantation Completed

Showing the 4 most-cited and recently-updated of 4 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.